Grant

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

CountryUnited States
Deadline2028-01-07 (411 days left)
Published2024-10-28
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-024. CFDA: 93.853, 93.866

The buyer, the value, the full description and the link to the official notice are available with a free account.